The rapid rise of weight-loss drugs like Ozempic and Wegovy is changing how people approach dieting. These medications, called GLP-1 drugs, reduce appetite and slow digestion. Millions of users have achieved significant weight loss with their help. However, scientists warn that important questions about long-term effects remain unanswered.
ALSO READ: CONCER TO DOUBLE BY 2050
Safety Concerns Over Long-Term Use
One major concern is the long-term safety of GLP-1 drugs. Ozempic was approved in 2017 and Wegovy in 2021. This means researchers have only a few years of data. Doctors still do not fully understand the risks of using these drugs for five years or longer. Potential problems include stomach paralysis, kidney issues, and pancreas-related complications. It is also unclear what happens when users stop the medication after long-term use.
Effects on the Brain Remain Unclear
Researchers are studying how GLP-1 drugs affect the brain. These drugs act on regions linked to hunger and reward. They may change cravings, motivation, and even behaviors connected to addiction. Early studies show that the drugs may reshape eating habits. However, the full neurological impact is still unknown.
Limited Information on Pregnancy
Pregnancy is another area with limited data. Clinical trials required participants to avoid pregnancy, leaving information on fertility and fetal development scarce. Reports of unexpected pregnancies are increasing among users. Doctors currently recommend stopping GLP-1 drugs two months before trying to conceive, though this guidance is based on limited evidence.
Ongoing Research on Other Health Effects
Scientists are also examining potential effects on muscle loss, bone density, and chronic diseases such as heart disease and Alzheimer’s. Early findings are promising, but more research is needed. Experts note that gaps in knowledge are expected because long-term data only emerge after widespread use. With global demand rising, clearer answers are expected in the next three to seven years.
Advice for Patients
Doctors stress that GLP-1 drugs are highly effective for weight loss. However, these treatments are still new and evolving. Patients should understand that their full risk profile has not yet been established.
